Feed Preview

Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma

Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma diagram by Public Domain, Wikimedia
Public Domain, Wikimedia

The cervix contains two types of cells and when cancer arises from squamous cells within the cervix it is cervical squamous cell carcinoma. The endocervix is located just above the body of the cervix and contains glandular cells. When cancer begins here it is called endocervical adenocarcinoma. Here is the latest research on these two types of cancers.

Top 20 most recent papers
Gynecologic Oncology

Low-grade serous ovarian cancer: State of the science

Gynecologic OncologyJanuary 24, 2020
Brian SlomovitzDavid M Gershenson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

CUE-101, a Novel HPV16 E7-pHLA-IL-2-Fc Fusion Protein, Enhances Tumor Antigen Specific T Cell Activation for the Treatment of HPV16-Driven Malignancies

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchJanuary 23, 2020
Steven N QuayleMary Ellen Simcox
Gynecologic Oncology

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

Gynecologic OncologyJanuary 22, 2020
Karen A CadooJason A Konner
Gynecologic Oncology

Second-line lenvatinib in patients with recurrent endometrial cancer

Gynecologic OncologyJanuary 21, 2020
Ignace VergoteRichard T Penson
Gynecologic Oncology

Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma

Gynecologic OncologyJanuary 20, 2020
Marta Llaurado FernandezMark S Carey
Gynecologic Oncology

Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1

Gynecologic OncologyJanuary 19, 2020
Melissa A MeridethPamela Stratton
Gynecologic Oncology

Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities

Gynecologic OncologyJanuary 20, 2020
Jennifer VazKathleen M Darcy
Gynecologic Oncology

Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities

Gynecologic OncologyJanuary 20, 2020
Nicole B GaulinKathleen M Darcy
Gynecologic Oncology

Comparison between laparoscopy and laparotomy in the surgical re-staging of granulosa cell tumors of the ovary

Gynecologic OncologyJanuary 20, 2020
M PeirettiA Maggioni
Gynecologic Oncology

Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study

Gynecologic OncologyJanuary 20, 2020
Koji MatsuoDavid M Gershenson
International Journal of Radiation Oncology, Biology, Physics

Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells

International Journal of Radiation Oncology, Biology, PhysicsJanuary 22, 2020
Laura BourillonCéline Bourgier
International Journal of Clinical and Experimental Pathology

Coexistence of adenoid cystic carcinoma and squamous cell carcinoma of the uterine cervix with HPV 16 infection: clinical course of delayed adjuvant treatment

International Journal of Clinical and Experimental PathologyJanuary 15, 2020
Yong Jung SongKi Hyung Kim
Gynecologic Oncology

Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women

Gynecologic OncologyJanuary 23, 2020
Tingyuan LiWen Chen
Gynecologic Oncology

Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: A single center experience

Gynecologic OncologyJanuary 20, 2020
Dan WangYang Xiang
Virchows Archiv : an International Journal of Pathology

Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type

Virchows Archiv : an International Journal of PathologyJanuary 15, 2020
Shiho AsakaHiroyoshi Ota
Gynecologic Oncology

Primary malignant ovarian carcinoid; management and outcomes

Gynecologic OncologyJanuary 22, 2020
Dimitrios NasioudisKevin Holcomb
Gynecologic Oncology

The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN)

Gynecologic OncologyJanuary 20, 2020
Hyun-Woong ChoJae Kwan Lee
Gynecologic Oncology

Whole transcriptome analysis of gestational trophoblastic neoplasms reveals altered PI3K signaling pathway in epithelioid trophoblastic tumor

Gynecologic OncologyJanuary 20, 2020
Eun Jeong ChoKyu-Rae Kim
Gynecologic Oncology

Surgical technique for the sentinel lymph node (SLN) mapping in 10 steps

Gynecologic OncologyJanuary 21, 2020
Sara ParacchiniNicolas Bourdel
Gynecologic Oncology

Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma

Gynecologic OncologyJanuary 21, 2020
Fu JunDazun Shi

See more papers from this feed

Related Feeds

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Kidney Carcinoma

Kidney or renal carcinoma is a malignant tumor that start in the kidney. Renal cell carcinoma and transitional cell carcinoma are the two most common types of kidney cancer. Several factors, both genetic and environmental, have been implicated in this cancer. Here is the latest research.

MicroRNAs in prostate cancer

MicroRNAs are small non-coding RNAs that modulate gene expression at post-transcriptional level, playing a crucial role in diseases such as prostate cancer. Discover the latest research on MicroRNAs in prostate cancer.

Ovarian Cancer

Ovarian cancers, benign or malignant, originate in cells of the ovaries. They are classified based on their tissue or origin, which includes the totipotent germ cells, epithelium, and the stromal endocrine cells. Here is the latest research.

Penile Neoplasms

Penile cancer is tumor or cancer cells that occur on or within the penis. It is a rare form of cancer that is found in males, particularly in North America. Discover the latest research on penile neoplasms here.

Prostate Adenocarcinoma

Prostate cancer is one of the most common types of cancer in men. Age, race, family history, and obesity are factors associated with increased prostate cancer risk. Here is the latest research on prostate adenocarcinoma.

Prostate Stem Cells

Prostate stem cells are important for the development, maturation and function of the prostate. They can give rise to three types of prostate epithelial cells and have been implicated in both benign prostate hyperplasia and prostate cancer. Here is the latest research on prostate stem cells.

Renal Cell Carcinoma

Renal cell carcinoma, the most common type of kidney cancer, originates in the lining of the proximal convoluted tubule. Both genetic and lifestyle factors have been implicated with increased risk of developing this cancer. Here is the latest research on renal cell carcinoma.

Testicular Germ Cell Tumors

Majority of testicular cancers originate in germ cells. Testicular germ cell tumors are the most common solid tumors in adolescent and young men. Here is the latest research on factors that influence this cancer and its management.

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms are the most common urinary system malignancy. Signs and symptoms of bladder cancer include hematuria, pelvic pain, and painful urination. Discover the latest research on bladder cancer here.

© 2020 Meta ULC. All rights reserved